Evidence map›Paper›PMID 24434316›Full record

ReviewThe Indian journal of medical research2013

Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases.

Rajeev K Pandey, Fu-Shin Yu, Ashok Kumar

Abstract readReview
In one paragraph

Review in The Indian journal of medical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Advances in the molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. The Immunopathogenesis of uveitis.Frontiers in medicine · 2026
    Review
  3. Review
  4. Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Toll-like receptor 2 (TLR2) engages endoplasmic reticulum stress sensor IRE1α to regulate retinal innate responses in Staphylococcus aureus endophthalmitis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rajeev K Pandey
Fu-Shin Yu
Ashok KumarDepartment of Ophthalmology, Kresge Eye Institute; Department of Anatomy & Cell Biology, Wayne State University School of Medicine, Detroit, MI, USA.
Kresge Eye Institute · USWayne State University · US

Funding

Mechanisms of flagellin-induced protection against microbial keratitisR01EY017960 · NEI · WAYNE STATE UNIVERSITY · PI YU, FU-SHIN X · 2008 to 2020
$4.8M
Toll-like receptors and bacterial endophthalmitisR01EY019888 · NEI · WAYNE STATE UNIVERSITY · PI KUMAR, ASHOK · 2010 to 2014
$1.6M
NEI NIH HHS R01 EY017960
6 · The paper itself

Abstract

Toll-like receptors (TLRs) play a key role in the innate immune response to invading pathogens. Thus, their discovery has opened up a wide range of therapeutic possibilities for various infectious and inflammatory diseases. In the last several years, extensive research efforts have provided a considerable wealth of information on the expression and function of TLRs in the eye, with significant implications for better understanding of pathogenesis of infectious eye diseases affecting the cornea, uvea, and the retina. In this review, by using bacterial keratitis and endophthalmitis as examples, we discuss the possibilities of targeting TLR signaling for the prevention or treatment of ocular infectious diseases.

Indexed as

Molecular Targeted TherapyCorneaEndophthalmitisEye InfectionsHumansImmunity, InnateInflammationKeratitisNF-kappa BSignal TransductionToll-Like ReceptorsNF-kappa BToll-Like Receptors

Identifiers

PMID24434316
PMCPMC3928694
OpenAlexW2146094953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.